Immatics NV (IMTX)
9.42
-0.11
(-1.15%)
USD |
NASDAQ |
Sep 01, 16:00
9.42
0.00 (0.00%)
After-Hours: 20:00
Immatics Cash from Operations (TTM) : -241.73M for June 30, 2026
Cash from Operations (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Operations (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | -241.73M |
| March 31, 2026 | -218.77M |
| December 31, 2025 | -205.58M |
| September 30, 2025 | -197.06M |
| June 30, 2025 | -180.74M |
| March 31, 2025 | -169.18M |
| December 31, 2024 | -168.57M |
| September 30, 2024 | -23.57M |
| June 30, 2024 | -18.26M |
| March 31, 2024 | 9.660M |
| December 31, 2023 | 19.60M |
| September 30, 2023 | |
| June 30, 2023 | |
| March 31, 2023 |
| Date | Value |
|---|---|
| December 31, 2022 | |
| September 30, 2022 | |
| June 30, 2022 | 124.89M |
| March 31, 2022 | 49.01M |
| December 31, 2021 | -93.44M |
| September 30, 2021 | -97.09M |
| June 30, 2021 | -133.21M |
| March 31, 2021 | -90.92M |
| December 31, 2020 | -102.02M |
| September 30, 2020 | -41.70M |
| June 30, 2020 | 68.01M |
| March 31, 2020 | 44.46M |
| December 31, 2019 | 75.34M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (TTM) Benchmarks
| MediGene AG | -- |
| InflaRx NV | -32.60M |
| BioNTech SE | 725.62M |
| Moderna, Inc. | -1.073B |
| Intellia Therapeutics, Inc. | -346.64M |